ZACKS INVESTMENT MANAGEMENT - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$72,000
-85.0%
15,835
-87.2%
0.00%
-90.0%
Q3 2020$480,000
-20.7%
123,776
-2.5%
0.01%
-23.1%
Q2 2020$605,000126,9970.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$29,914,6092.82%
Eversept Partners, LP 5,183,046$7,204,4340.50%
TPG GP A, LLC 12,328,767$17,136,9860.28%
CM Management, LLC 150,000$2090.25%
Signature Wealth Management Partners, LLC 87,666$121,8560.11%
Hedges Asset Management LLC 84,600$117,5940.10%
Tranquilli Financial Advisor LLC 71,414$99,2650.07%
Virtus Fund Advisers, LLC 6,941$9,6480.07%
Nantahala Capital Management 500,000$695,0000.05%
XTX Topco Ltd 175,500$243,9450.05%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders